The DNA methylation profile of non-coding RNAs improves prognosis prediction for pancreatic adenocarcinoma

被引:11
|
作者
Zhang, Jie [1 ]
Shi, Keqing [2 ]
Huang, Weiguo [1 ]
Weng, Wanqing [1 ]
Zhang, Zhongjing [1 ]
Guo, Yangyang [1 ]
Deng, Tuo [1 ]
Xiang, Yukai [1 ]
Ni, Xiaofeng [1 ]
Chen, Bicheng [1 ]
Zhou, Mengtao [1 ,2 ]
机构
[1] Wenzhou Med Univ, Affiliated Hosp 1, Key Lab Diag & Treatment Severe Hepatopancreat Di, Wenzhou 325015, Zhejiang, Peoples R China
[2] Wenzhou Med Univ, Precis Med Ctr, Affiliated Hosp 1, Wenzhou 325015, Zhejiang, Peoples R China
关键词
DNA methylation; Pancreatic adenocarcinoma; miRNA; lncRNA; Classifier; Prognosis; GASTRIC-CANCER; PROMOTES; EXPRESSION; CELLS; MAPK;
D O I
10.1186/s12935-019-0828-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundCompelling lines of evidence indicate that DNA methylation of non-coding RNAs (ncRNAs) plays critical roles in various tumour progression. In addition, the differential methylation of ncRNAs can predict prognosis of patients. However, little is known about the clear relationship between DNA methylation profile of ncRNAs and the prognosis of pancreatic adenocarcinoma (PAC) patients.MethodsThe data of DNA methylation, RNA-seq, miRNA-seq and clinical features of PAC patients were collected from TCGA database. The DNA methylation profile was obtained using the Infinium HumanMethylation450 BeadChip array. LASSO regression was performed to construct two methylation-based classifiers. The risk score of methylation-based classifiers was calculated for each patient, and the accuracy of the classifiers in predicting overall survival (OS) was examined by ROC curve analysis. In addition, Cox regression models were utilized to assess whether clinical variables and the classifiers were independent prognostic factors for OS. The targets of miRNA and the genes co-expressed with lncRNA were identified with DIANA microT-CDS and the Multi-Experiment Matrix (MEM), respectively. Moreover, DAVID Bioinformatics Resources were applied to analyse the functional enrichment of these targets and co-expressed genes.ResultsA total of 4004 CpG sites of miRNA and 11,259 CpG sites of lncRNA were screened. Among these CpG sites, 8 CpG sites of miRNA and 7 CpG sites of lncRNA were found with regression coefficients. By multiplying the sum of methylation degrees of the selected CpGs with these coefficients, two methylation-based classifiers were constructed. The classifiers have shown good performance in predicting the survival rate of PAC patients at varying follow-up times. Interestingly, both of these two classifiers were predominant and independent factors for OS. Furthermore, functional enrichment analysis demonstrated that aberrantly methylated miRNAs and lncRNAs are related to calcium ion transmembrane transport and MAPK, Ras and calcium signalling pathways.ConclusionIn the present study, we identified two methylation-based classifiers of ncRNA associated with OS in PAC patients through a comprehensive analysis of miRNA and lncRNA profiles. We are the first group to demonstrate a relationship between the aberrant DNA methylation of ncRNAs and the prognosis of PAC, and this relationship would contribute to individualized PAC therapy.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Biocomputational prediction of non-coding RNAs in model cyanobacteria
    Björn Voß
    Jens Georg
    Verena Schön
    Susanne Ude
    Wolfgang R Hess
    BMC Genomics, 10
  • [42] Biocomputational prediction of non-coding RNAs in model cyanobacteria
    Voss, Bjoern
    Georg, Jens
    Schoen, Verena
    Ude, Susanne
    Hess, Wolfgang R.
    BMC GENOMICS, 2009, 10
  • [43] Genome-wide DNA methylation regulation analysis of long non-coding RNAs in glioblastoma
    Ji, Jianghuai
    Zhao, Lei
    Zhao, Xiaoxiao
    Li, Qianpeng
    An, Yi
    Li, Li
    Li, Dongguo
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2020, 46 (01) : 224 - 238
  • [44] Biocomputational prediction of small non-coding RNAs in Streptomyces
    Panek, Josef
    Bobek, Jan
    Mikulik, Karel
    Basler, Marek
    Vohradsky, Jiri
    BMC GENOMICS, 2008, 9 (1)
  • [45] Role of non-coding RNAs and exosomal non-coding RNAs in retinoblastoma progression
    Ahangar Davoodi, Nasrin
    Najafi, Sajad
    Naderi Ghale-Noie, Zari
    Piranviseh, Ashkan
    Mollazadeh, Samaneh
    Ahmadi Asouri, Sahar
    Asemi, Zatollah
    Morshedi, Mohammadamin
    Tamehri Zadeh, Seyed Saeed
    Hamblin, Michael R.
    Sheida, Amirhossein
    Mirzaei, Hamed
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [46] Non-coding RNAs as clinical biomarkers for cancer diagnosis and prognosis
    Mishra, Prasun J.
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2014, 14 (08) : 917 - 919
  • [47] Non-coding RNA biomarkers in pancreatic ductal adenocarcinoma
    Sharma, Geeta G.
    Okada, Yasuyuki
    Von Hoff, Daniel
    Goel, Ajay
    SEMINARS IN CANCER BIOLOGY, 2021, 75 : 153 - 168
  • [48] DNA rearrangements directed by non-coding RNAs in ciliates
    Mochizuki, Kazufumi
    WILEY INTERDISCIPLINARY REVIEWS-RNA, 2010, 1 (03) : 376 - 387
  • [49] A Long Non-coding RNA Signature to Improve Prognostic Prediction of Pancreatic Ductal Adenocarcinoma
    Zhou, Chenhao
    Wang, Shun
    Zhou, Qiang
    Zhao, Jin
    Xia, Xianghou
    Chen, Wanyong
    Zheng, Yan
    Xue, Min
    Yang, Feng
    Fu, Deliang
    Yin, Yirui
    Atyah, Manar
    Qin, Lunxiu
    Zhao, Yue
    Bruns, Christiane
    Jia, Huliang
    Ren, Ning
    Dong, Qiongzhu
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [50] Survival prediction model with long non-coding RNA profile in lung adenocarcinoma cancer
    Wang, Wei-An
    Lai, Liang-Chuan
    Tsai, Mong-Hsun
    Liu, Tzu-Pin
    Chuang, Eric Y.
    CANCER RESEARCH, 2015, 75